Dr. Oldham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Redstone Ave W
Crestview, FL 32536Phone+1 850-683-0003Fax+1 850-640-0761
Summary
- Dr. Robert Oldham is an oncologist in Brunswick, GA and is affiliated with SE GA Health System. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice 49 years. He specializes in hematologic oncology.
Education & Training
Vanderbilt University Medical CenterResidency, Internal Medicine, 1968 - 1970
University of Missouri-Columbia School of MedicineClass of 1968
Certifications & Licensure
DC State Medical License 1974 - Present
FL State Medical License 2011 - 2025
GA State Medical License 1999 - 2025
MO State Medical License 1991 - 2023
NM State Medical License 2007 - 2020
WV State Medical License 2015 - 2019
IL State Medical License 2010 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors Start of enrollment: 1990 Sep 01
Publications & Presentations
PubMed
- 121 citationsInhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®Robert W. Robey, Suneet Shukla, Elizabeth M. Finley, Robert K. Oldham, Daryl Barnett
Biochemical Pharmacology. 2008-03-15 - 398 citationsHuman Anti-Murine Immunoglobulin Responses in Patients Receiving Monoclonal Antibody TherapyRobert W. Schroff, Kenneth A. Foon, Shannon M. Beatty, Robert K. Oldham, Alton C. Morgan
Cancer Research. 1985-02-01 - 16 citationsA phase I and pharmacokinetic study of CBT-1 as a multidrug resistance modulator in the treatment of patients with advanced cancerRobert K. Oldham, William K. Reid, Harvey D. Preisler, Daryl Barnett
Cancer Biotherapy & Radiopharmaceuticals. 1998-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
